These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21561048)

  • 1. Dietary salt reduction and cardiovascular disease.
    Nair M; Prabhakaran D
    Natl Med J India; 2010; 23(6):352-3. PubMed ID: 21561048
    [No Abstract]   [Full Text] [Related]  

  • 2. Projected effect of dietary salt reductions on future cardiovascular disease.
    Bibbins-Domingo K; Chertow GM; Coxson PG; Moran A; Lightwood JM; Pletcher MJ; Goldman L
    N Engl J Med; 2010 Feb; 362(7):590-9. PubMed ID: 20089957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary salt reductions and cardiovascular disease.
    Graudal N; Jürgens G
    N Engl J Med; 2010 Jun; 362(23):2225; author reply 2225-6. PubMed ID: 20568308
    [No Abstract]   [Full Text] [Related]  

  • 4. Dietary salt reductions and cardiovascular disease.
    de Borst MH; Navis G
    N Engl J Med; 2010 Jun; 362(23):2224-5; author reply 2225-6. PubMed ID: 20568307
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial.
    Ohsfeldt RL; Gandhi SK; Smolen LJ; Jensen MM; Fox KM; Gold A; Hsia J
    J Med Econ; 2010; 13(3):428-37. PubMed ID: 20662625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of interventions to reduce dietary salt intake.
    Cobiac LJ; Vos T; Veerman JL
    Heart; 2010 Dec; 96(23):1920-5. PubMed ID: 21041840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of medical nutrition therapy and therapeutically designed meals for older adults with cardiovascular disease.
    Troyer JL; McAuley WJ; McCutcheon ME
    J Am Diet Assoc; 2010 Dec; 110(12):1840-51. PubMed ID: 21111094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential societal savings from reduced sodium consumption in the U.S. adult population.
    Palar K; Sturm R
    Am J Health Promot; 2009; 24(1):49-57. PubMed ID: 19750962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food and vessels: the importance of a healthy diet to prevent cardiovascular disease.
    Engelfriet P; Hoekstra J; Hoogenveen R; Büchner F; van Rossum C; Verschuren M
    Eur J Cardiovasc Prev Rehabil; 2010 Feb; 17(1):50-5. PubMed ID: 19593150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of occupational circulatory disease.
    Leigh JP; Schnall P
    Occup Med; 2000; 15(1):257-67, v. PubMed ID: 10702089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary salt and risk factors for cardiovascular disease.
    Beilin LJ
    Kidney Int Suppl; 1992 Jun; 37():S90-6. PubMed ID: 1630079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular prevention in the over-80 age group is beneficial].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):26. PubMed ID: 18240757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summaries for patients. Are there cost-effective ways to help people eat less salt?
    Ann Intern Med; 2010 Apr; 152(8):I27. PubMed ID: 20194227
    [No Abstract]   [Full Text] [Related]  

  • 18. Societal costs of obstructive sleep apnoea syndrome.
    Gander P; Scott G; Mihaere K; Scott H
    N Z Med J; 2010 Aug; 123(1321):13-23. PubMed ID: 20927153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.
    Gaziano TA
    Heart; 2008 Feb; 94(2):140-4. PubMed ID: 18195120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.